BSE filing, NSE: AARTIPHARM. Summary written from the filing by ALFA Finder's alert engine.
Aarti Pharmalabs Ltd: key numbers
- Share price
- ₹997.95
- Market cap
- ₹9,049 Cr
- Revenue (annual)
- ₹1,819 Cr
- Net profit (annual)
- ₹174.7 Cr
- P/E (TTM)
- 35.2×Sector 43.7×
- Promoter holding
- 39.66%-3.20% QoQ
- FII holding
- 8.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarti Pharmalabs Ltd
All →Aarti Pharmalabs Earnings Call Transcript: Key Takeaways
Aarti Pharmalabs delivered record quarterly revenue driven by strong CDMO growth, though aggressive capex is temporarily elevating debt and working capital.
- Call
- Guides 45% growth
Aarti Pharmalabs Investor Presentation: Key Takeaways
Q2 FY27 standalone revenue INR 6,126Mn (+46.8% YoY), EBITDA INR 1,358Mn (22.2% margin), PAT INR 658Mn (+180% YoY). H1 revenue +44.7%. Xanthine capacity expansion and Atali capex drive growth.
Aarti Pharmalabs Management Change
Aarti Pharmalabs accepted CFO Piyush Lakhani's resignation, effective 30 October 2026, and appointed Vibha Thakker as CFO from 31 October 2026. The filing records a senior management change with no monetary amount.
Aarti Pharmalabs Q2 FY27 Results: Net Profit ₹71.5 Cr, Up 248.8% YoY
Aarti Pharmalabs Ltd reported revenue from operations of ₹610.5 Cr (+45.9% YoY) and net profit of ₹71.5 Cr (+248.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹71.5 Cr · +248.8% YoY
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
Other other announcement announcements
All →Unicommerce eSolutions Other Announcement
Unicommerce cancelled its 18 November 2026 CLSA group investor meeting due to exigencies. The filing carries no financial or business event.
Valiant Organics Other Announcement
Valiant Organics reports the demise of Chairman Emeritus Chandrakant Gogri, a Promoter Group member. He has ceased to be a Promoter Group member under Regulation 31A(6)(c).
Aarti Industries Other Announcement
Aarti Industries announced the demise of promoter and Chairman Emeritus Chandrakant Gogri on November 15, 2026. He ceases to be a promoter under Regulation 31A(6)(c).
Aarti Drugs Other Announcement
Aarti Drugs announced the demise of promoter and Chairman Emeritus Chandrakant Gogri on November 15, 2026. He ceases to be a promoter under Regulation 31A(6)(c).
Valiant Laboratories Other Announcement
Valiant Laboratories disclosed the demise of promoter group member Chandrakant Gogri on November 15, 2026. He ceases to be promoter group under Regulation 31A(6)(c).
Ellenbarrie Industrial Gases Other Announcement
Ellenbarrie filed its IPO monitoring agency report for the quarter ended September 30, 2026. Proceeds were utilised as per the offer document, with no deviations.